Cite Filings / APUS / 0001213900-26-017331

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Apimeds Pharmaceuticals US, Inc. Filed 2026-02-17 Acc 0001213900-26-017331

Documents 1

425 Prospectus/Communication re Business Combination , ea0277267-8ka2_api.htm

Around this filing

2026-04-09 425 Prospectus/Communication re Business Combination
2026-02-17 425 Prospectus/Communication re Business Combination
2026-02-17 8-K/A Acquisition or sale completed
2026-02-11 SCHEDULE 13G Statement of Beneficial Ownership
2025-12-02 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ea0277267-8ka2_api.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…